← All indications
Angina, Unstable
Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.
Subtype terms (1)
More specific conditions that are subtypes of Angina, Unstable in the MeSH hierarchy.
- Angina Pectoris, Variant
5 drugs approved
Drugs by status
Approved for this indication (5)
Phase 4 trials (29)
- metformin
- nitroglycerin
- heparin
- argatroban
- dabigatran
- danhong
- wen xin
- metoclopramide
- atorvastatin
- ticagrelor
- prasugrel
- sitagliptin
- salvianolate
- acetylsalicylic acid
- shuanghe
- bupropion
- xuefu zhuyu
- rivaroxaban
- metoprolol
- pinellia
- morphine
- naloxone
- danzhen
- sodium chloride
- methoxyflurane
- isosorbide
- dalteparin
- nicorandil
- trimetazidine
Phase 3 trials (10)
Phase 2 trials (6)
Organizations
Organization Involved with Phase 4 Indications (49)
- Pfizer
- GlaxoSmithKline
- Green Valley Group of China
- IHF GmbH - Institut für Herzinfarktforschung
- Kobe University
- Mochida Pharmaceutical Company, Ltd.
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Roma La Sapienza
- Ajou University
- Central South University
- Canadian Heart Research Centre
- China Academy of Chinese Medical Sciences
- Harvard University
- Duke University
- Gelderse Vallei Hospital
- Korea University
- Meander Medical Center
- Rijnstate Hospital
- Seoul National University
- University of Saskatchewan
- University of Toronto
- Utrecht University
- Yonsei University
- Capital Medical University
- Peking University
- Xiamen University
- Leiden University
- Dr. A. Jurasz University
- The Royal Wolverhampton NHS Trust
- University of Mannheim
- +19 more
Organization Involved with Phase 3 Indications (25)
- Medicure
- Centocor
- AtheroGenics
- Bayer
- Eurofarma Laboratorios S.A.
- University of Pittsburgh
- Rhode Island Hospital
- Rutgers University
- Tufts University
- University of Florence
- Urmia University of Medical Sciences
- University of Cologne
- SCRI Development Innovations
- University of Montreal
- University of Sao Paulo
- Western Infirmary
- Linkoping University
- Washington University in St. Louis
- University of Tuebingen
- The Swedish Research Council
- Swedish Heart Lung Foundation
- Swedish Foundation for Strategic Research
- Acrostak
- Yeshiva University
- Johnson and Johnson
Organization Involved with Phase 2 Indications (9)
Organization Involved with Other Experimental Indications (2)